Inhaled mannitol for cystic fibrosis
Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group
Published Online: 4 AUG 2010
Assessed as up-to-date: 30 JUN 2010
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Thornton J, Murray CS, Elkins M, Dwyer T. Inhaled mannitol for cystic fibrosis (Protocol). Cochrane Database of Systematic Reviews 2010, Issue 8. Art. No.: CD008649. DOI: 10.1002/14651858.CD008649.
- Publication Status: New
- Published Online: 4 AUG 2010
This is the protocol for a review and there is no abstract. The objectives are as follows:
To assess whether inhaled dry powder mannitol is well tolerated and whether it improves the respiratory function, reduces respiratory exacerbations and improves the quality of life of people with CF.